quizartinib
daiichi sankyo
['quantum-first', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'quizartinib']
congress | #ash22 richard schlenk presents results from the quantum-first trial where quizartinib treatment was associated with longer survival versus placebo in patients with newly diagnosed mflt3-itd aml who underwent allo-hsct in cr1. #leusm #amlsm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm